Important New Research on Tranexamic Acid!

June 20, 2026

New Research Highlights the Anti-Aging Potential of Topical Tranexamic Acid

A newly published study by Lin et al. in the peer-reviewed journal Annals of Medicine has added to the growing body of research surrounding tranexamic acid (TXA), an ingredient already well known in skincare for helping improve the appearance of uneven skin tone and discoloration.

The Lin study found that topical tranexamic acid not only improved the appearance of early wrinkles around the eyes, but also helped protect key skin-supporting cells from the effects of oxidative stress, a major contributor to visible skin aging.

For those of us who have been following the science of tranexamic acid closely, these findings are both exciting and encouraging.

What Did the Researchers Find?

Lin and colleagues evaluated a 3% topical tranexamic acid formulation in women with facial pigmentation concerns and observed improvements in the appearance of fine lines and wrinkles around the eyes compared with moisturizer alone.

Beyond the clinical observations, the researchers also investigated what was happening at the cellular level. Their findings suggest that tranexamic acid helps support the health of dermal fibroblasts—the cells responsible for creating collagen and elastin, which maintain skin structure, firmness, and resilience.

The study reported that tranexamic acid helped reduce oxidative stress, support the skin’s natural defense systems, and decrease cellular signals commonly associated with visible skin aging.

The authors concluded that topical tranexamic acid may be a promising ingredient for supporting healthier-looking skin as we age.

Why These Findings Matter

For many years, tranexamic acid has primarily been discussed in connection with skin tone concerns. However, emerging research like the Lin study indicates that its benefits extend well beyond complexion improvement alone.

Lin builds upon prior research from Pins et al. finding that plasmin degrades collagen, and that a plasmin inhibitor can block these effects of plasmin. Pins used a different plasmin inhibitor, but tranexamic acid is also an established plasmin inhibitor. Plasmin is an inflammatory protein created by the body in response to injury, including exposure to UV light.

In addition, Endo et al. found that tranexamic acid protects fibroblasts against producing disrupted collagen and fibrillin-1 fibers after the fibroblasts were exposed to UV-A radiation.

Thus the growing body of research shows that tranexamic acid protects collagen from degradation by sunlight exposure, and promotes production of healthy collagen and other factors supporting the normal youthful appearance of skin.

Healthy-looking skin depends on much more than pigmentation. Factors such as environmental stress, free radicals, inflammation, and the long-term health of skin-supporting cells all play an important role in how skin ages over time.

This new research helps expand our understanding of tranexamic acid’s potential role in supporting skin quality, resilience, and overall appearance.

Independent Research Reinforces What We’ve Long Believed

At NextLeap Skin Care, these findings are particularly meaningful because they align with the scientific direction we have pursued for years.

In fact, NextLeap Skin Care holds patent rights related to the use of topical tranexamic acid for skin-aging applications. Our patent portfolio reflects our long-standing belief that tranexamic acid offers cosmetic benefits that extend beyond its traditional use in addressing uneven skin tone and special cosmetic issues like melasma, rosacea and cold sores.

While the Lin publication represents independent academic research, the results are directionally consistent with the broader understanding that has guided our own innovation efforts.

We view this study as an important step forward in helping the scientific and skincare communities better understand the versatility and potential of topical tranexamic acid.

The NextLeap Glow Difference

The formulation evaluated in this study contained 3% tranexamic acid. NextLeap Glow utilizes a 10% tranexamic acid concentration that has been specifically developed for cosmetic use.

Through our formulation development and internal testing, we have found that NextLeap Glow remains gentle and well tolerated while delivering the performance characteristics we seek in a daily-use skincare product.

Importantly, concentration alone does not determine product performance. Formulation design, ingredient compatibility, stability, and overall user experience all play a critical role in creating an effective skincare product.

Our goal has always been to develop a sophisticated tranexamic acid formulation that maximizes cosmetic benefits while maintaining a pleasant and gentle user experience.

Looking Ahead

As scientific interest in tranexamic acid continues to grow, we expect to see additional research exploring its broader role in supporting healthy-looking skin.

We are encouraged to see independent researchers investigating mechanisms and benefits that align with areas we have long considered important.

For consumers, this growing body of evidence highlights why tranexamic acid is increasingly recognized as one of the most exciting and versatile ingredients in modern skincare.

Read the Full Study

Lin Y, Wang Y, Wang W, et al. Tranexamic acid protects human dermal fibroblasts from D-galactose-induced senescence via the GPR30/MAPK pathway. Annals of Medicine. 2026;58(1).

DOI: https://doi.org/10.1080/07853890.2026.2663263

Reference

This article discusses findings reported in the peer-reviewed publication:

Lin Y, Wang Y, Wang W, et al. Tranexamic acid protects human dermal fibroblasts from D-galactose-induced senescence via the GPR30/MAPK pathway. Annals of Medicine. 2026;58(1). DOI: 10.1080/07853890.2026.2663263.